Xinyi Luo

772 total citations
30 papers, 507 citations indexed

About

Xinyi Luo is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Xinyi Luo has authored 30 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Xinyi Luo's work include CRISPR and Genetic Engineering (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers) and RNA Interference and Gene Delivery (3 papers). Xinyi Luo is often cited by papers focused on CRISPR and Genetic Engineering (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers) and RNA Interference and Gene Delivery (3 papers). Xinyi Luo collaborates with scholars based in China, United States and Hong Kong. Xinyi Luo's co-authors include Yuanyan Liu, Zhenglai Hua, Liuchunyang Yu, Cheng Lü, Xiaoxia Xue, Ting Zhao, Jianhua Zhou, Ming Li, Jiasi Wang and Yang Li and has published in prestigious journals such as Analytical Chemistry, Oncogene and ACS Applied Materials & Interfaces.

In The Last Decade

Xinyi Luo

27 papers receiving 500 citations

Peers

Xinyi Luo
Xinyi Luo
Citations per year, relative to Xinyi Luo Xinyi Luo (= 1×) peers Xiaobin Ma

Countries citing papers authored by Xinyi Luo

Since Specialization
Citations

This map shows the geographic impact of Xinyi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyi Luo more than expected).

Fields of papers citing papers by Xinyi Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyi Luo. The network helps show where Xinyi Luo may publish in the future.

Co-authorship network of co-authors of Xinyi Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyi Luo. A scholar is included among the top collaborators of Xinyi Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyi Luo. Xinyi Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Hang, Xiaoyu Wu, Lan Li, et al.. (2025). TLL1 knockdown attenuates prostate cancer progression by enhancing antitumor immunity. Oncogene. 44(38). 3580–3597.
2.
Zhang, Zhengjia, Xinyi Luo, Xiaoxia Xue, et al.. (2024). Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppressive Microenvironment. International Journal of Nanomedicine. Volume 19. 743–758. 17 indexed citations
3.
Luo, Xinyi, Ke Wang, Yingying Xue, et al.. (2024). Digital PCR-free technologies for absolute quantitation of nucleic acids at single-molecule level. Chinese Chemical Letters. 36(2). 109924–109924. 5 indexed citations
6.
7.
Hussein, M., Xinyi Luo, Peter P. Issa, et al.. (2024). Treatment outcomes in patients with papillary thyroid cancer undergoing radiofrequency ablation of metastatic lymph nodes. Gland Surgery. 13(10). 1752–1758. 2 indexed citations
8.
Lu, Na, Di Su, Jialei Chen, et al.. (2024). Design of novel chiral self-assembling peptides to explore the efficiency and mechanism of mRNA-FIPV vaccine delivery vehicles. International Journal of Pharmaceutics. 660. 124344–124344. 1 indexed citations
9.
Cao, Zhiwen, Rui Liu, Yang Li, et al.. (2023). MTX-PEG-modified CG/DMMA polymeric micelles for targeted delivery of doxorubicin to induce synergistic autophagic death against triple-negative breast cancer. Breast Cancer Research. 25(1). 3–3. 21 indexed citations
10.
Issa, Peter P., M. Hussein, Xinyi Luo, et al.. (2023). Completion thyroidectomy: A safe option for high‐volume surgeons. Head & Neck. 46(1). 57–63. 2 indexed citations
11.
Issa, Peter P., Mohammad H. Hussein, Xinyi Luo, et al.. (2023). Comparison of Medical Management versus Parathyroidectomy in Patients with Mild Primary Hyperparathyroidism: A Meta-Analysis. Cancers. 15(12). 3085–3085. 3 indexed citations
12.
Yang, Li, Xinyi Luo, Zhenglai Hua, et al.. (2023). Apolipoproteins as potential communicators play an essential role in the pathogenesis and treatment of early atherosclerosis. International Journal of Biological Sciences. 19(14). 4493–4510. 13 indexed citations
13.
Zhang, Zhengjia, Liuchunyang Yu, Yang Li, et al.. (2022). The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies. Frontiers in Immunology. 12. 807895–807895. 60 indexed citations
14.
Hua, Zhenglai, Xinyi Luo, Yang Li, et al.. (2022). Application and pharmacological mechanism of methotrexate in rheumatoid arthritis. Biomedicine & Pharmacotherapy. 150. 113074–113074. 79 indexed citations
15.
Ma, Xingming, et al.. (2021). Effect of blended learning with BOPPPS model on Chinese student outcomes and perceptions in an introduction course of health services management. AJP Advances in Physiology Education. 45(2). 409–417. 42 indexed citations
16.
Luo, Xinyi, et al.. (2021). 15-Year Experience with Multimodality Therapy Including Esophagectomy for Elderly Patients with Locoregional Esophageal Cancer. Journal of the American College of Surgeons. 232(4). 580–588. 3 indexed citations
17.
Luo, Xinyi, Yingying Xue, Enguo Ju, et al.. (2021). Digital CRISPR/Cas12b-based platform enabled absolute quantification of viral RNA. Analytica Chimica Acta. 1192. 339336–339336. 44 indexed citations
19.
Danielle, S., et al.. (2019). Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder. Expert Review of Neurotherapeutics. 19(9). 777–783. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026